Screening for Interacting Proteins with Peptide Biomarker of Blood–Brain Barrier Alteration under Inflammatory Conditions

Neurodegenerative diseases are characterized by increased permeability of the blood–brain barrier (BBB) due to alterations in cellular and structural components of the neurovascular unit, particularly in association with neuroinflammation. A previous screening study of peptide ligands to identify mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Vargas-Sanchez, Karina, Losada-Barragán, Monica, Mogilevskaya, Maria, Novoa-Herrán, Susana, Medina, Yehidi, Buendía-Atencio, Cristian, Lorett-Velásquez, Vaneza, Martínez-Bernal, Jessica, Gonzalez-Reyes, Rodrigo E., Ramírez, David, Petry, Klaus G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124558/
https://www.ncbi.nlm.nih.gov/pubmed/33946948
http://dx.doi.org/10.3390/ijms22094725

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124558/
https://www.ncbi.nlm.nih.gov/pubmed/33946948
http://dx.doi.org/10.3390/ijms22094725

Ejemplares similares